OpenURL Connection Search

Select item for more details and to access through your institution.

Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.897991
By:
- Hong, David S.;
- Gopal, Ajay K.;
- Shoushtari, Alexander N.;
- Patel, Sandip P.;
- He, Aiwu R.;
- Toshihiko Doi;
- Ramalingam, Suresh S.;
- Patnaik, Amita;
- Sandhu, Shahneen;
- Ying Chen;
- Davis, Craig B.;
- Fisher, Timothy S.;
- Bo Huang;
- Fly, Kolette D.;
- Ribas, Antoni
Publication type:
Article
A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma.
Published in:
Investigational New Drugs, 2024, v. 42, n. 2, p. 179, doi. 10.1007/s10637-024-01419-1
By:
- Beckermann, Kathryn E.;
- Patnaik, Amita;
- Winer, Ira;
- Tan, Winston;
- Bashir, Babar;
- Kyriakopoulos, Christos E.;
- Sweis, Randy F.;
- Chamberlain, Marc;
- Rini, Brian I.
Publication type:
Article
First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.
Published in:
Investigational New Drugs, 2022, v. 40, n. 3, p. 586, doi. 10.1007/s10637-022-01217-7
By:
- Berlin, Jordan;
- Tolcher, Anthony W.;
- Ding, Cliff;
- Whisenant, Jennifer G.;
- Horak, Ivan D.;
- Wood, Debra L.;
- Nadler, Paul I.;
- Hansen, Ulla Holm;
- Lantto, Johan;
- Skartved, Niels Jørgen Ø.;
- Pedersen, Mikkel W.;
- Patnaik, Amita
Publication type:
Article
A phase 1 study of LY3076226, a fibroblast growth factor receptor 3 (FGFR3) antibody–drug conjugate, in patients with advanced or metastatic cancer.
Published in:
Investigational New Drugs, 2021, v. 39, n. 6, p. 1613, doi. 10.1007/s10637-021-01146-x
By:
- Kollmannsberger, Christian;
- Britten, Carolyn D.;
- Olszanski, Anthony J.;
- Walker, Joan Andrews;
- Zang, Wei;
- Willard, Melinda D.;
- Radtke, David B.;
- Farrington, Daphne L.;
- Bell-McGuinn, Katherine M.;
- Patnaik, Amita
Publication type:
Article
A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors.
Published in:
Investigational New Drugs, 2019, v. 37, n. 4, p. 722, doi. 10.1007/s10637-018-0714-6
By:
- Smith, David C.;
- Chugh, Rashmi;
- Patnaik, Amita;
- Papadopoulos, Kyriakos P.;
- Wang, Min;
- Kapoun, Ann M.;
- Xu, Lu;
- Dupont, Jakob;
- Stagg, Robert J.;
- Tolcher, Anthony
Publication type:
Article
Phase 1 and pharmacokinetic study of LY3007113, a p38 MAPK inhibitor, in patients with advanced cancer.
Published in:
Investigational New Drugs, 2018, v. 36, n. 4, p. 629, doi. 10.1007/s10637-017-0532-2
By:
- Goldman, Jonathan W.;
- Rosen, Lee S.;
- Tolcher, Anthony W.;
- Papadopoulos, Kyriakos;
- Beeram, Muralidhar;
- Shi, Peipei;
- Pitou, Celine;
- Bell, Robert;
- Kulanthaivel, Palaniappan;
- Zhang, Xuekui;
- Fink, Aaron;
- Chan, Edward M.;
- Shahir, Ashwin;
- Farrington, Daphne;
- Patnaik, Amita
Publication type:
Article
A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid Tumors.
Published in:
Cancers, 2022, v. 14, n. 20, p. 4996, doi. 10.3390/cancers14204996
By:
- Patnaik, Amita;
- Hamilton, Erika;
- Xing, Yan;
- Rasco, Drew W.;
- Smith, Lon;
- Lee, Ya-Li;
- Fang, Steven;
- Wei, Jiao;
- Hui, Ai-Min
Publication type:
Article
A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2014, v. 32, n. 4, p. 653, doi. 10.1007/s10637-014-0071-z
By:
- Weekes, Colin;
- Beeram, Muralidhar;
- Tolcher, Anthony;
- Papadopoulos, Kyriakos;
- Gore, Lia;
- Hegde, Priti;
- Xin, Yan;
- Yu, Ron;
- Shih, L.;
- Xiang, Hong;
- Brachmann, Rainer;
- Patnaik, Amita
Publication type:
Article
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer.
Published in:
2007
By:
- Hecht, J. Randolph;
- Patnaik, Amita;
- Berlin, Jordan;
- Venook, Alan;
- Malik, Imtiaz;
- Tchekmedyian, Simon;
- Navale, Lynn;
- Amado, Rafael G.;
- Meropol, Neal J.
Publication type:
journal article
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.
Published in:
2017
By:
- Bendell, Johanna C;
- Javle, Milind;
- Bekaii-Saab, Tanios S;
- Finn, Richard S;
- Wainberg, Zev A;
- Laheru, Daniel A;
- Weekes, Colin D;
- Tan, Benjamin R;
- Khan, Gazala N;
- Zalupski, Mark M;
- Infante, Jeffrey R;
- Jones, Suzanne;
- Papadopoulos, Kyriakos P;
- Tolcher, Anthony W;
- Chavira, Renae E;
- Christy-Bittel, Janna L;
- Barrett, Emma;
- Patnaik, Amita
Publication type:
journal article
Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial.
Published in:
2018
By:
- Papadopoulos, Kyriakos P.;
- Ben-Ami, Eytan;
- Patnaik, Amita;
- Trone, Denise;
- Li, Jianke;
- Demetri, George D.
Publication type:
journal article
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial.
Published in:
Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 1, p. 93, doi. 10.1007/s00280-021-04358-3
By:
- Patnaik, Amita;
- Weiss, Glen J.;
- Rasco, Drew W.;
- Blaydorn, Lisa;
- Mirabella, Amy;
- Beeram, Murali;
- Guo, Wei;
- Lu, Sharon;
- Danaee, Hadi;
- McEachern, Kristen;
- Im, Ellie;
- Sachdev, Jasgit C.
Publication type:
Article
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.
Published in:
2018
By:
- Patnaik, Amita;
- Papadopoulos, Kyriakos P.;
- Rasco, Drew;
- Beeram, Muralidhar;
- Gordon, Michael;
- Tsai, Frank;
- Fu, Siqing;
- Janku, Filip;
- Hong, David;
- Hynes, Scott M.;
- Gundala, Sushma R.;
- Willard, Melinda D.;
- Zhang, Wei;
- Lin, Aimee Bence
Publication type:
journal article
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer.
Published in:
2018
By:
- Patnaik, Amita;
- Papadopoulous, Kyri;
- Rasco, Drew;
- Beeram, S. Muralidhar;
- Gordon, Michael;
- Tsai, Frank;
- Fu, Siqing;
- Janku, Filip;
- Hong, David;
- Hynes, Scott M.;
- Gundala, Sushma R.;
- Willard, Melinda D.;
- Zhang, Wei;
- Lin, Aimee Bence;
- Papadopoulos, Kyriakos P;
- Beeram, Muralidhar
Publication type:
journal article
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer.
Published in:
2017
By:
- Infante, Jeffrey;
- Patnaik, Amita;
- Verschraegen, Claire;
- Olszanski, Anthony;
- Shaheen, Montaser;
- Burris, Howard;
- Tolcher, Anthony;
- Papadopoulos, Kyriakos;
- Beeram, Muralidhar;
- Hynes, Scott;
- Leohr, Jennifer;
- Lin, Aimee;
- Li, Lily;
- McGlothlin, Anna;
- Farrington, Daphne;
- Westin, Eric;
- Cohen, Roger;
- Infante, Jeffrey R;
- Verschraegen, Claire F;
- Olszanski, Anthony J
Publication type:
journal article
Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours.
Published in:
2016
By:
- Patnaik, Amita;
- Tolcher, Anthony;
- Papadopoulos, Kyriakos;
- Beeram, Murali;
- Rasco, Drew;
- Werner, Theresa;
- Bauman, John;
- Scheuber, Anita;
- Cox, Donna;
- Patel, Bela;
- Zhou, YanYan;
- Hamid, Mohammed;
- Schramek, Daniel;
- Sharma, Sunil;
- Papadopoulos, Kyriakos P;
- Werner, Theresa L;
- Bauman, John W;
- Cox, Donna S;
- Patel, Bela R
Publication type:
journal article
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 587, doi. 10.1007/s00280-015-2830-8
By:
- Patnaik, Amita;
- Tolcher, Anthony;
- Beeram, Murali;
- Nemunaitis, John;
- Weiss, Glen;
- Bhalla, Kapil;
- Agrawal, Manish;
- Nichols, Gwen;
- Middleton, Steven;
- Beryozkina, Anna;
- Sarapa, Nenad;
- Peck, Richard;
- Zhi, Jianguo
Publication type:
Article
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 183, doi. 10.1007/s00280-014-2615-5
By:
- Tolcher, Anthony;
- Patnaik, Amita;
- Papadopoulos, Kyriakos;
- Rasco, Drew;
- Becerra, Carlos;
- Allred, Alicia;
- Orford, Keith;
- Aktan, Gursel;
- Ferron-Brady, Geraldine;
- Ibrahim, Nageatte;
- Gauvin, Jennifer;
- Motwani, Monica;
- Cornfeld, Mark
Publication type:
Article
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 951, doi. 10.1007/s00280-014-2426-8
By:
- Patnaik, Amita;
- LoRusso, Patricia;
- Messersmith, Wells;
- Papadopoulos, Kyriakos;
- Gore, Lia;
- Beeram, Muralidhar;
- Ramakrishnan, Vanitha;
- Kim, Amy;
- Beyer, Joseph;
- Mason Shih, L.;
- Darbonne, Walter;
- Xin, Yan;
- Yu, Ron;
- Xiang, Hong;
- Brachmann, Rainer;
- Weekes, Colin
Publication type:
Article
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 2, p. 363, doi. 10.1007/s00280-013-2361-0
By:
- Tolcher, Anthony;
- Rodrigueza, Wendi;
- Rasco, Drew;
- Patnaik, Amita;
- Papadopoulos, Kyriakos;
- Amaya, Alex;
- Moore, Timothy;
- Gaylor, Shari;
- Bisgaier, Charles;
- Sooch, Mina;
- Woolliscroft, Michael;
- Messmann, Richard
Publication type:
Article
A phase I/II study of carfilzomib 2-10-min infusion in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 4, p. 861, doi. 10.1007/s00280-013-2267-x
By:
- Papadopoulos, Kyriakos;
- Burris, Howard;
- Gordon, Michael;
- Lee, Peter;
- Sausville, Edward;
- Rosen, Peter;
- Patnaik, Amita;
- Cutler, Richard;
- Wang, Zhengping;
- Lee, Susan;
- Jones, Suzanne;
- Infante, Jeffery
Publication type:
Article
Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1499, doi. 10.1007/s00280-013-2149-2
By:
- Patnaik, Amita;
- Papadopoulos, Kyriakos;
- Tolcher, Anthony;
- Beeram, Muralidhar;
- Urien, Saïk;
- Schaaf, Larry;
- Tahiri, Sanaa;
- Bekaii-Saab, Tanios;
- Lokiec, François;
- Rezaï, Keyvan;
- Buchbinder, Aby
Publication type:
Article
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1041, doi. 10.1007/s00280-013-2099-8
By:
- Sandhu, Shahneen;
- Papadopoulos, Kyri;
- Fong, Peter;
- Patnaik, Amita;
- Messiou, Christina;
- Olmos, David;
- Wang, George;
- Tromp, Brenda;
- Puchalski, Thomas;
- Balkwill, Frances;
- Berns, Birge;
- Seetharam, Shobha;
- Bono, Johann;
- Tolcher, Anthony
Publication type:
Article
A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer.
Published in:
2012
By:
- Lush RM;
- Patnaik A;
- Sullivan D;
- Papadopoulos KP;
- Trucksis M;
- McCrea J;
- Cerchio K;
- Li X;
- Stroh M;
- Selverian D;
- Orford K;
- Ebbinghaus S;
- Agrawal N;
- Iwamoto M;
- Wagner JA;
- Tolcher A;
- Lush, Richard M;
- Patnaik, Amita;
- Sullivan, Daniel;
- Papadopoulos, Kyriakos P
Publication type:
journal article
A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 4, p. 567, doi. 10.1007/s00280-012-1942-7
By:
- Lush, Richard;
- Patnaik, Amita;
- Sullivan, Daniel;
- Papadopoulos, Kyriakos;
- Trucksis, Michele;
- McCrea, Jacqueline;
- Cerchio, Kristine;
- Li, Xiaodong;
- Stroh, Mark;
- Selverian, Diana;
- Orford, Keith;
- Ebbinghaus, Scot;
- Agrawal, Nancy;
- Iwamoto, Marian;
- Wagner, John;
- Tolcher, Anthony
Publication type:
Article
Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1565, doi. 10.1007/s00280-011-1639-3
By:
- Saif, Muhammad;
- Sarantopoulos, John;
- Patnaik, Amita;
- Tolcher, Anthony;
- Takimoto, Chris;
- Beeram, Murali
Publication type:
Article
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
By:
- Chia-Chi Lin;
- Beeram, Muralidhar;
- Rowinsky, Eric K.;
- Takimoto, Chris H.;
- Ng, Chee M.;
- Geyer Jr., Charles E.;
- Denis, Louis J.;
- De Bono, Johann S.;
- Hao, Desiree;
- Tolcher, Anthony W.;
- Rha, Sun-Young;
- Jolivet, Jacques;
- Patnaik, Amita
Publication type:
Article
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x
By:
- Chia-Chi Lin;
- Calvo, Emiliano;
- Papadopoulos, Kyriakos P.;
- Patnaik, Amita;
- Sarantopoulos, John;
- Mita, Alain C.;
- Preston, Glenn G.;
- Mita, Monica M.;
- Rodon, Jordi;
- Mays, Theresa;
- I.-Tien Yeh;
- O'Rourke, Pat;
- Takimoto, Chris H.;
- Dancey, Janet E.;
- Chen, Helen;
- Tolcher, Anthony W.
Publication type:
Article
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.
Published in:
Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 295, doi. 10.1007/s00280-006-0389-0
By:
- Dragovich, Tomislav;
- Huberman, Mark;
- Von Hoff, Daniel D.;
- Rowinsky, Eric K.;
- Nadler, Paul;
- Wood, Debra;
- Hamilton, Marta;
- Hage, George;
- Wolf, Julie;
- Patnaik, Amita
Publication type:
Article
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
Published in:
Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 165, doi. 10.1007/s00280-006-0255-0
By:
- Mita, Monica M.;
- Rowinsky, Eric K.;
- Forero, Leonardo;
- Eckhart, S. Gail;
- Izbicka, Elzbieta;
- Weiss, Geoffrey R.;
- Beeram, Muralidhar;
- Mita, Alain C.;
- de Bono, Johann S.;
- Tolcher, Anthony W.;
- Hammond, Lisa A.;
- Simmons, Paul;
- Berg, Kristin;
- Takimoto, Chris;
- Patnaik, Amita
Publication type:
Article
Lack of Meaningful Effect of Ridaforolimus on the Pharmacokinetics of Midazolam in Cancer Patients: Model Prediction and Clinical Confirmation.
Published in:
Journal of Clinical Pharmacology, 2014, v. 54, n. 11, p. 1256, doi. 10.1002/jcph.331
By:
- Stroh, Mark;
- Talaty, Jennifer;
- Sandhu, Punam;
- McCrea, Jacqueline;
- Patnaik, Amita;
- Tolcher, Anthony;
- Palcza, John;
- Orford, Keith;
- Breidinger, Sheila;
- Narasimhan, Narayana;
- Panebianco, Deborah;
- Lush, Richard;
- Papadopoulos, Kyriakos P.;
- Wagner, John A.;
- Trucksis, Michele;
- Agrawal, Nancy
Publication type:
Article
Evaluation of the Effects of Food on the Single-Dose Pharmacokinetics of Trametinib, a First-in-Class MEK Inhibitor, in Patients with Cancer.
Published in:
Journal of Clinical Pharmacology, 2013, v. 53, n. 9, p. 946, doi. 10.1002/jcph.115
By:
- Cox, Donna S.;
- Papadopoulos, Kyri;
- Fang, Lei;
- Bauman, John;
- LoRusso, Patricia;
- Tolcher, Anthony;
- Patnaik, Amita;
- Pendry, Carolyn;
- Orford, Keith;
- Ouellet, Daniele
Publication type:
Article
Depressive Symptoms among COVID-19 patients: A cross-sectional study in the field practice area of District Mental Health Programme Unit, Ganjam.
Published in:
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2022, v. 13, n. 5, p. 971
By:
- Tripathy, Chandra Sekhar;
- Sahu, Bibhu Kalyan;
- Patnaik, Amita;
- Mishra, Biswakalyan;
- Purohit, SarojKumar
Publication type:
Article
TESTICULAR PERFUSION AND FERTILITY EFFECT IN PATIENT UNDERGOING LICHTENSTEIN INGUINAL HERNIOPLASTY: A PROSPECTIVE STUDY DEPARTMENT OF GENERAL SURGERY, MKCG MCH.
Published in:
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2022, v. 13, n. 5, p. 590
By:
- Mallick, Sworupa Nanda;
- Mahapatra, Swapna;
- Patnaik, Amita;
- Bag, Lachhaman;
- Swain, Narendra Nath;
- Amitav, Suvendhu
Publication type:
Article
A PROSPECTIVE STUDY OF PRESENTATION AND PROGNOSIS OF CARBUNCLE IN MKCG MEDICAL COLLEGE AND HOSPITAL OF SOUTHERN ODISHA.
Published in:
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2022, v. 13, n. 5, p. 585
By:
- Bag, Lachhaman;
- Patnaik, Amita;
- Mahapatra, Swapna;
- Mallick, Sworupa Nanda;
- Amitav, Suvendhu;
- Swain, NarendraNath
Publication type:
Article
A study of Sociodemographic profile of HIV /AIDS children visiting ART centre and impact on orphanhood.
Published in:
Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2022, v. 13, n. 5, p. 1
By:
- Panda, Sadhana;
- Singh, Hemanta Kumar;
- Sahu, Minakhi Kumari;
- Patnaik, Amita
Publication type:
Article
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.
Published in:
Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1
By:
- Rhoda Molife, L.;
- Li Yan;
- Vitfell-Rasmussen, Joanna;
- Zernhelt, Adriane M.;
- Sullivan, Daniel M.;
- Cassier, Philippe A.;
- Eric Chen;
- Biondo, Andrea;
- Tetteh, Ernestina;
- Siu, Lillian L.;
- Patnaik, Amita;
- Papadopoulos, Kyriakos P.;
- De Bono, Johann S.;
- Tolcher, Anthony W.;
- Minton, Susan
Publication type:
Article
Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
Published in:
2022
By:
- Patnaik, Amita;
- Gadgeel, Shirish;
- Papadopoulos, Kyriakos P.;
- Rasco, Drew W.;
- Haas, Naomi B.;
- Der-Torossian, Hirak;
- Faltaos, Demiana;
- Potvin, Diane;
- Tassell, Vanessa;
- Tawashi, Manal;
- Chao, Richard;
- O'Dwyer, Peter J.
Publication type:
Correction Notice
Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
Published in:
Targeted Oncology, 2022, v. 17, n. 2, p. 125, doi. 10.1007/s11523-022-00875-0
By:
- Patnaik, Amita;
- Gadgeel, Shirish;
- Papadopoulos, Kyriakos P.;
- Rasco, Drew W.;
- Haas, Naomi B.;
- Der-Torossian, Hirak;
- Faltaos, Demiana;
- Potvin, Diane;
- Tassell, Vanessa;
- Tawashi, Manal;
- Chao, Richard;
- O'Dwyer, Peter J.
Publication type:
Article
A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.
Published in:
Oncologist, 2018, v. 23, n. 6, p. 658, doi. 10.1634/theoncologist.2017-0325
By:
- Tolcher, Anthony;
- Flaherty, Keith;
- Shapiro, Geoffrey I.;
- Berlin, Jordan;
- Witzig, Thomas;
- Habermann, Thomas;
- Bullock, Andrea;
- Rock, Edwin;
- Elekes, Agnes;
- Lin, Chester;
- Kostic, Dusan;
- Ohi, Naoto;
- Rasco, Drew;
- Papadopoulos, Kyriakos P.;
- Patnaik, Amita;
- Smith, Lon;
- Cote, Gregory M.
Publication type:
Article
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
Published in:
2016
By:
- Ribas, Antoni;
- Hamid, Omid;
- Daud, Adil;
- Stephen Hodi, F.;
- Wolchok, Jedd D.;
- Kefford, Richard;
- Joshua, Anthony M.;
- Patnaik, Amita;
- Hwu, Wen-Jen;
- Weber, Jeffrey S.;
- Gangadhar, Tara C.;
- Hersey, Peter;
- Dronca, Roxana;
- Joseph, Richard W.;
- Zarour, Hassane;
- Chmielowski, Bartosz;
- Lawrence, Donald P.;
- Algazi, Alain;
- Rizvi, Naiyer A.;
- Hoffner, Brianna
Publication type:
journal article
Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer.
Published in:
Journal of Ovarian Research, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1757-2215-6-2
By:
- Gunn, Shelly;
- Reveles, Xavier;
- Weldon, Korrie;
- Barrera, Andres;
- Ishaque, Mariam;
- Taylor, Dale;
- McCaskill, Chris;
- Kim, Jaeweon;
- Shah, Rashmi;
- Mohammed, Mansoor;
- Barry, Todd;
- Kaiser, Brianne;
- Patnaik, Amita;
- Tolcher, Anthony
Publication type:
Article

Found: 42